| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | VP &Chief Financial Officer
2 companies
Girao Tiago serves as a Chief Financial Officer at IMVT and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 1 buy and 2 sells. Those positions are worth an estimated $9.9M at current prices.
The biggest single holding is IMVT (~$9.9M) as Chief Financial Officer. The recent filings there lean toward selling, a net 16,798 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 23, 2026 | IMVT Immunovant, Inc. | Chief Financial Officer | Sell | 6,798 | $38.69 | $263,014.62 | -2.7% | - | - | |
| Jun 26, 2026 | IMVT Immunovant, Inc. | Chief Financial Officer | Sale+OE | 10,000 | $38.46 | $384,600.00 | -3.9% | - | - | |
| Aug 18, 2015 | PSTV Plus Therapeutics, Inc. | VP &Chief Financial Officer | Buy | 25,000 | $0.39 | $9,750.00 | +39.7% | - | - |